Latest Articles

Publication Date
Characterization of shared neoantigens landscape in Mismatch Repair Deficient Endometrial Cancer - Nature.com

Characterization of shared neoantigens landscape in Mismatch Repair Deficient Endometrial Cancer Nature.com

Published: Dec. 20, 2024, 10:34 a.m.
Endometriosis-associated primary clear cell adenocarcinoma of the urinary bladder: A case report and literature review.

Primary clear cell adenocarcinoma (CCA) of the urinary bladder is a rare and aggressive malignancy. Few reports in the literature describe this presentation, as associated with malignant transformation of endometriosis. …

Published: Dec. 20, 2024, midnight
Lunresertib Plus Camonsertib Produces Durable Responses in Advanced Endometrial, Ovarian Cancer - OncLive

Lunresertib Plus Camonsertib Produces Durable Responses in Advanced Endometrial, Ovarian Cancer OncLive

Published: Dec. 19, 2024, 4:30 p.m.
GSK’s Cancer Drug Jemperli Nears EU Marketing Expansion - MSN

GSK’s Cancer Drug Jemperli Nears EU Marketing Expansion MSN

Published: Dec. 19, 2024, 1:50 p.m.
Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without RT for Newly Diagnosed, High-Risk Endometrial Cancer: Results in DMMR Tumors - Medpage Today

Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without RT for Newly Diagnosed, High-Risk Endometrial Cancer: Results in DMMR Tumors Medpage Today

Published: Dec. 18, 2024, 8:16 p.m.
ASCO Reading Room | The Evolving Treatment Landscape for High-Risk Endometrial Cancer - Medpage Today

ASCO Reading Room | The Evolving Treatment Landscape for High-Risk Endometrial Cancer Medpage Today

Published: Dec. 18, 2024, 3:59 p.m.
Brian Slomovitz on Adjuvant Pembrolizumab/Chemotherapy for Advanced Endometrial Cancer - Medpage Today

Brian Slomovitz on Adjuvant Pembrolizumab/Chemotherapy for Advanced Endometrial Cancer Medpage Today

Published: Dec. 18, 2024, 3:27 p.m.
GSK’s Jemperli receives positive CHMP opinion for expanded endometrial cancer use - PMLiVE

GSK’s Jemperli receives positive CHMP opinion for expanded endometrial cancer use PMLiVE

Published: Dec. 18, 2024, 12:25 p.m.
Molecular Classification Drives Advances in Endometrial Cancer Treatment - Journal of Clinical Pathways

Molecular Classification Drives Advances in Endometrial Cancer Treatment Journal of Clinical Pathways

Published: Dec. 17, 2024, 3:25 p.m.
GSK’s Cancer Drug Jemperli Moves a Step Closer to European Marketing Permission - MSN

GSK’s Cancer Drug Jemperli Moves a Step Closer to European Marketing Permission MSN

Published: Dec. 17, 2024, 1:27 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!